Literature DB >> 1124762

Hereditary persistence of fetal hemoglobin, beta thalassemia, and the hemoglobin delta-beta locus: further family data and genetic interpretations.

N C Bethlenfalvay, A G Motulsky, B Ringelhann, H Lehmann, J R Humbert, F I Konotey-Ahulu.   

Abstract

Three Negro kindreds with hereditary persistence of fetal hemoglobin (HPFH) alone and in combination with various other hemoglobin abnormalities including beta thalassemia are presented. Among 11 offspring of two women heterozygous for both HPFH and the delta chain mutation Hb B2, five inherited the HPFH gene and six inherited the Hb B2 gene. In another kindred, a man inferred to be heterozygous for both HPFH and Hb C had six children; three offsprivg obtained the Hb C gene and three the HPFH gene. Similarly, a woman heterozygous for both Hb S and HPFH transmitted the Hb S gene to one of her two children and the HPFH gene to the other. Thus among 19 offspring, no crossovers between the HPFH locus or the Hb delta-beta locus were observed. These and earlier data are compatible with deletion of the Hb beta and delta loci as the primary event to explain the genetic origin of HPFH. Genetic considerations indicate that the finding of a single person with a hematologically normal phenotype among offspring of heterozygotes for both the African type of HPFH and a Hb beta or Hb delta structural abnormality would invalidate the deletion model.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1124762      PMCID: PMC1762752     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN IN GREECE. A STUDY AND A COMPARISON.

Authors:  P FESSAS; G STAMATOYANNOPOULOS
Journal:  Blood       Date:  1964-09       Impact factor: 22.113

2.  HUMAN HEMOGLOBIN GENE LINKAGE: REPORT OF A FAMILY WITH HEMOGLOBIN B2, HEMOGLOBIN S, AND BETA THALASSEMIA, INCLUDING A PROBABLE CROSSOVER BETWEEN THALASSEMIA AND DELTA LOCI.

Authors:  H A PEARSON; M M MOORE
Journal:  Am J Hum Genet       Date:  1965-03       Impact factor: 11.025

3.  CHARACTERIZATION OF GENETIC VARIANTS OF BLOOD PROTEINS.

Authors:  O SMITHIES
Journal:  Vox Sang       Date:  1965 May-Jun       Impact factor: 2.144

4.  Hereditary persistence of fetal hemoglobin: a study of 79 affected persons in 15 Negro families in Baltimore.

Authors:  C L CONLEY; D J WEATHERALL; S N RICHARDSON; M K SHEPARD; S CHARACHE
Journal:  Blood       Date:  1963-03       Impact factor: 22.113

5.  The homozygous state of persistent fetal hemoglobin and the interaction of persistent fetal hemoglobin with thalassemia.

Authors:  J T WHEELER; J R KREVANS
Journal:  Bull Johns Hopkins Hosp       Date:  1961-11

6.  Independence of whole blood and haemoglobin solution oxygen dissociation curves from haemoglobin type.

Authors:  J J SCHRUEFER; C J HELLER; F C BATTAGLIA; A E HELLEGERS
Journal:  Nature       Date:  1962-11-10       Impact factor: 49.962

7.  A family with S and C hemoglobins and the hereditary persistence of F hemoglobin. A comparison of C thalassemia disease with the CF syndrome.

Authors:  R G SCHNEIDER; W C LEVIN; C EVERETT
Journal:  N Engl J Med       Date:  1961-12-28       Impact factor: 91.245

8.  Hereditary persistence of foetal haemoglobin: a family study suggesting allelism of the F gene to the S and C haemoglobin genes.

Authors:  J E MACIVER; L N WENT
Journal:  Br J Haematol       Date:  1961-07       Impact factor: 6.998

9.  The hemoglobin genes: a remarkable example of the clustering of related genetic functions on a single mammalian chromosome.

Authors:  J V NEEL
Journal:  Blood       Date:  1961-12       Impact factor: 22.113

10.  Controller genes in synthesis of human haemoglobin.

Authors:  A G MOTULSKY
Journal:  Nature       Date:  1962-05-12       Impact factor: 49.962

View more
  2 in total

1.  Clinical genetics: ghanaian gratitude for british and hungarian contributions: a personalized historical perspective.

Authors:  Felix I D Konotey-Ahulu
Journal:  Ghana Med J       Date:  2009-12

2.  A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease.

Authors:  Jo Howard; Claire Jane Hemmaway; Paul Telfer; D Mark Layton; John Porter; Moji Awogbade; Timothy Mant; Daniel D Gretler; Kobina Dufu; Athiwat Hutchaleelaha; Mira Patel; Vincent Siu; Sandra Dixon; Noel Landsman; Margaret Tonda; Joshua Lehrer-Graiwer
Journal:  Blood       Date:  2019-01-17       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.